Good day. Dominic Barfield here and this is the RVC Clinical Podcast. Thank you for listening and

thank you for subscribing on your smartphone or generic fruit brace device. We're really

grateful for you taking the time to download and listen to this, obviously, podcast. We don't

ask for much in return. Be incredibly grateful if you could pop to Apple Podcasts or ACAST and leave us

a review. Obviously a five-star review would be great, but we'd greatly appreciate a moment, a couple minutes of time to leave us for review.

So still joining Brian myself remotely. We're not in this studio.

Is Dr. Irina Grima, one of our oncologists, one of our lectures in oncology, that's the word I was missing,

here at the RVC. So thank you, Er erina for joining us even though it's remotely but that

seems to be the new norm now thank you dom thanks for the introduction so i thought what we're

going to talk about would be about her mangy of sarkema and see something that i know that

both of our sort of services see sort of quite quite a lot and sort of

would be good to have a sort of catch up about what we're what we're doing at the moment and

are there things that we're we're looking to sort of in the future so um so maybe if we could just

ask by saying is it is is our imagoia sarcomas like a common part of,

a common neoplasia of the things that you see on the oncology service, is quite common for you?

Yes, Dom.

I would definitely say so.

And I think the sort of interesting and exciting factor about those tumours is that they definitely require

a multidisciplinary approach. So a lot of the time, our classic example would be the dog

presenting with a hemoatamine, and that has to be seen as an emergency, and hence will come

through our ECC service primarily and will require

surgical intervention and obviously stabilisation through that and then gets passed on to the

...